NCT00457925View on ClinicalTrials.gov

Absorption, Distribution, Metabolism And Excretion Study For GSK221149A

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

October 31, 2006

Conditions
Obstetric Labour, PrematurePremature Labor
Interventions
DRUG

GSK221149A

Trial Locations (1)

53704

GSK Investigational Site, Madison

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY